{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:29:47Z","timestamp":1707524987972},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,28]]},"DOI":"10.7759\/cureus.34314","type":"journal-article","created":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T22:40:33Z","timestamp":1674945633000},"source":"Crossref","is-referenced-by-count":1,"title":["Moyamoya Syndrome (MMS) in a Patient With Sickle Cell Disease (SCD) and Protein S Deficiency"],"prefix":"10.7759","author":[{"given":"Parima","family":"Saxena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussam","family":"Alkaissi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riddhi","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Muthu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-020-03977-9","article-title":"Pathophysiology and recent therapeutic insights of sickle cell disease","volume":"99","author":"Shah F","year":"2020","unstructured":"Shah F, Dwivedi M. Pathophysiology and recent therapeutic insights of sickle cell disease. Ann Hematol. 2020, 99:925-935. 10.1007\/s00277-020-03977-9","journal-title":"Ann Hematol"},{"key":"ref2","article-title":"Cerebrovascular accidents in sickle cell disease: rates and risk factors","volume":"91","author":"Ohene-Frempong K","year":"1998","unstructured":"Ohene-Frempong K, Weiner SJ, Sleeper LA, et al.. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998, 91:288-294.","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1586\/ehm.13.25","article-title":"Stroke in patients with sickle cell disease","volume":"6","author":"Webb J","year":"2013","unstructured":"Webb J, Kwiatkowski JL. Stroke in patients with sickle cell disease. Expert Rev Hematol. 2013, 6:301-316. 10.1586\/ehm.13.25","journal-title":"Expert Rev Hematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0804622","article-title":"Moyamoya disease and moyamoya syndrome","volume":"360","author":"Scott RM","year":"2009","unstructured":"Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009, 360:1226-1237. 10.1056\/NEJMra0804622","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2014-203727","article-title":"Moyamoya syndrome in sickle cell anaemia: a cause of recurrent stroke","volume":"2014","author":"Soares D","year":"2014","unstructured":"Soares D, Bullock R, Ali S. Moyamoya syndrome in sickle cell anaemia: a cause of recurrent stroke. BMJ Case Rep. 2014, 2014:bcr2014203727. 10.1136\/bcr-2014-203727","journal-title":"BMJ Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v99.9.3144","article-title":"Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events","volume":"99","author":"Dobson SR","year":"2002","unstructured":"Dobson SR, Holden KR, Nietert PJ, Cure JK, Laver JH, Disco D, Abboud MR. Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events. Blood. 2002, 99:3144-3150. 10.1182\/blood.v99.9.3144","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2018.11.157","article-title":"Surgical revascularization for pediatric patients with sickle cell disease and Moyamoya disease in the prevention of ischemic strokes: a single-center case series and a systematic review","volume":"123","author":"Aguilar-Salinas P","year":"2019","unstructured":"Aguilar-Salinas P, Hayward K, Santos R, Agarwal V, Sauvageau E, Hanel RA, Aldana PR. Surgical revascularization for pediatric patients with sickle cell disease and Moyamoya disease in the prevention of ischemic strokes: a single-center case series and a systematic review. World Neurosurg. 2019, 123:435.e8-442.e8. 10.1016\/j.wneu.2018.11.157","journal-title":"World Neurosurg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3171\/2017.1.PEDS16576","article-title":"Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome","volume":"20","author":"Yang W","year":"2017","unstructured":"Yang W, Xu R, Porras JL, et al.. Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome. J Neurosurg Pediatr. 2017, 20:232-238. 10.3171\/2017.1.PEDS16576","journal-title":"J Neurosurg Pediatr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2020.01.182","article-title":"Cerebral revascularization for Moyamoya syndrome associated with sickle cell disease: a systematic review of the literature on the role of extracranial-intracranial bypass in treating neurologic manifestations of pediatric patients with sickle cell disease","volume":"137","author":"Terrell D","year":"2020","unstructured":"Terrell D, Savardekar AR, Whipple SG, Dossani RH, Spetzler RF, Sun H. Cerebral revascularization for Moyamoya syndrome associated with sickle cell disease: a systematic review of the literature on the role of extracranial-intracranial bypass in treating neurologic manifestations of pediatric patients with sickle cell disease. World Neurosurg. 2020, 137:62-70. 10.1016\/j.wneu.2020.01.182","journal-title":"World Neurosurg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-11-392340","article-title":"Stroke with transfusions changing to hydroxyurea (SWiTCH)","volume":"119","author":"Ware RE","year":"2012","unstructured":"Ware RE, Helms RW. Stroke with transfusions changing to hydroxyurea (SWiTCH). Blood. 2012, 119:3925-3932. 10.1182\/blood-2011-11-392340","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001142","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults","volume":"4","author":"DeBaun MR","year":"2020","unstructured":"DeBaun MR, Jordan LC, King AA, et al.. American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults. Blood Adv. 2020, 4:1554-1588. 10.1182\/bloodadvances.2019001142","journal-title":"Blood Adv"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2010.09.021","article-title":"[Moya-moya in an adult with sickle cell anemia]","volume":"40","author":"Dion J","year":"2011","unstructured":"Dion J, Bachmeyer C, Favrole P, Marro B, Lionnet F. [Moya-moya in an adult with sickle cell anemia]. Presse Med. 2011, 40:450-451. 10.1016\/j.lpm.2010.09.021","journal-title":"Presse Med"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2020-134202","article-title":"Case report: acute stroke in young adult patient with Moyamoya syndrome secondary to sickle cell disease","volume":"136","author":"Cole O","year":"2020","unstructured":"Cole O, Filatov A, Khanni J, Espinosa P. Case report: acute stroke in young adult patient with Moyamoya syndrome secondary to sickle cell disease. Blood. 2020, 136:13.","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.10001","article-title":"Moyamoya syndrome in a 32-year-old male with sickle cell anemia","volume":"12","author":"Yamani M","year":"2020","unstructured":"Yamani M, Obaid EF, Hemida AH. Moyamoya syndrome in a 32-year-old male with sickle cell anemia. Cureus. 2020, 12:e10001. 10.7759\/cureus.10001","journal-title":"Cureus"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00015","article-title":"Characteristics of Moyamoya syndrome in sickle-cell disease by magnetic resonance angiography: an adult-cohort study","volume":"10","author":"Kauv P","year":"2019","unstructured":"Kauv P, Gaudr\u00e9 N, Hodel J, et al.. Characteristics of Moyamoya syndrome in sickle-cell disease by magnetic resonance angiography: an adult-cohort study. Front Neurol. 2019, 10:15. 10.3389\/fneur.2019.00015","journal-title":"Front Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/136192-moyamoya-syndrome-mms-in-a-patient-with-sickle-cell-disease-scd-and-protein-s-deficiency","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:56:13Z","timestamp":1707508573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/136192-moyamoya-syndrome-mms-in-a-patient-with-sickle-cell-disease-scd-and-protein-s-deficiency"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,28]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.34314","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,28]]}}}